Cambridge Investment Research Advisors, Inc. Cooper Companies, Inc. Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$306.88 - $380.0 $5,216 - $6,460	-17 Reduced 2.43%	682 $258,000
Q3 2023 Oct 24, 2023	SELL	$315.92 - $397.36 $947 - $1,192	-3 Reduced 0.43%	699 $222,000
Q2 2023 Jul 13, 2023	SELL	$346.15 - $392.09 $9,346 - $10,586	-27 Reduced 3.7%	702 $269,000
Q1 2023 May 11, 2023	BUY	$323.56 - $373.36 $323 - $373	1 Added 0.14%	729 $272,000
Q4 2022 Feb 08, 2023	BUY	$248.67 - $334.17 $181,031 - $243,275	728 New	728 $241,000
Q2 2022 Jul 13, 2022	BUY	$301.4 - $428.42 $2.72 Million - $3.87 Million	9,022 Added 1229.16%	9,756 $3.05 Million
Q1 2022 May 12, 2022	BUY	$379.46 - $424.54 $2,656 - $2,971	7 Added 0.96%	734 $306,000
Q4 2021 Feb 03, 2022	SELL	$373.53 - $434.12 $1,494 - $1,736	-4 Reduced 0.55%	727 $304,000
Q3 2021 Nov 02, 2021	SELL	$396.76 - $455.92 $12,696 - $14,589	-32 Reduced 4.19%	731 $302,000
Q2 2021 Aug 10, 2021	SELL	$372.36 - $412.07 $71,120 - $78,705	-191 Reduced 20.02%	763 $302,000
Q1 2021 May 07, 2021	BUY	$357.26 - $392.57 $10,003 - $10,991	28 Added 3.02%	954 $366,000
Q4 2020 Feb 04, 2021	SELL	$319.05 - $363.32 $13,081 - $14,896	-41 Reduced 4.24%	926 $336,000
Q3 2020 Oct 29, 2020	SELL	$280.08 - $347.78 $23,246 - $28,865	-83 Reduced 7.9%	967 $325,000
Q2 2020 Jul 27, 2020	SELL	$270.93 - $320.3 $27,363 - $32,350	-101 Reduced 8.77%	1,050 $297,000
Q1 2020 May 08, 2020	SELL	$243.44 - $359.98 $1,947 - $2,879	-8 Reduced 0.69%	1,151 $317,000
Q4 2019 Feb 04, 2020	SELL	$281.18 - $322.05 $3,092 - $3,542	-11 Reduced 0.94%	1,159 $372,000
Q3 2019 Nov 06, 2019	SELL	$294.25 - $341.49 $2.27 Million - $2.64 Million	-7,724 Reduced 86.85%	1,170 $347,000
Q3 2019 Oct 28, 2019	BUY	$294.25 - $341.49 $12,064 - $14,001	41 Added 0.46%	8,894 $2.64 Million
Q2 2019 Aug 15, 2019	BUY	$279.29 - $336.89 $42,452 - $51,207	152 Added 1.75%	8,853 $0
Q1 2019 May 08, 2019	BUY	$246.18 - $297.25 $48,743 - $58,855	198 Added 2.33%	8,701 $0
Q4 2018 Feb 05, 2019	SELL	$232.7 - $281.66 $22,571 - $27,321	-97 Reduced 1.13%	8,503 $2.16 Million
Q3 2018 Nov 02, 2018	SELL	$236.3 - $277.15 $33,790 - $39,632	-143 Reduced 1.64%	8,600 $0
Q2 2018 Aug 10, 2018	BUY	$217.98 - $237.23 $1.04 Million - $1.13 Million	4,758 Added 119.4%	8,743 $0
Q1 2018 May 09, 2018	BUY	$218.74 - $251.43 $241,488 - $277,578	1,104 Added 38.32%	3,985 $0
Q4 2017 Feb 22, 2018	SELL	$217.88 - $244.43 $22,877 - $25,665	-105 Reduced 3.52%	2,881 $0
Q3 2017 Nov 07, 2017	SELL	$231.6 - $253.39 $125,295 - $137,083	-541 Reduced 15.34%	2,986 $708,000
Q2 2017 Aug 08, 2017	BUY	N/A	3,527	3,527 $844,000

Others Institutions Holding COO

# of Institutions

Shares Held

1.59M

Call Options Held

Put Options Held

Intermede Investment Partners LTD

1.09M
Shares

$109 Million
2.52% of portfolio
Pictet Asset Management Sa Geneva 73, V8

143K
Shares

$14.2 Million
0.07% of portfolio
Brant Point Investment Management LLC New York, NY

109K
Shares

$10.9 Million
2.96% of portfolio
Eaton Vance Management Boston, MA

86.1K
Shares

$8.58 Million
0.03% of portfolio
Crystal Rock Capital Management

54.2K
Shares

$5.4 Million
3.65% of portfolio

View Full List

About COOPER COMPANIES, INC.

Ticker COO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 49,346,000
Market Cap $4.92B
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...

More about COO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account